Benuvia Manufacturing forms Senior Advisory Board
15 January 2021 -

United States-based Benuvia Manufacturing Inc, a CDMO providing small molecule active pharmaceutical ingredients, formulation and drug product manufacturing from preclinical to commercial scale, announced on Thursday that it has formed and hired new members to its Senior Advisory Board.

The new members of the Senior Advisory Board include Valeria Coscia, PhD, Bill DuBay, PhD, Paul Evans and Mike Wittmann, PhD.

Dr Coscia has more than 19 years of experience with broad responsibilities in various functional areas including research and development, portfolio management, GMP manufacturing and CMC regulatory affairs. She is an independent consultant in the Pharma industry. She has also served as vice president R&D and chief technology officer for Noramco Inc.

Dr. DuBay has over 25 years of experience in pharmaceutical research and development. He is the global head of R&D for SK Pharmteco. He has also served as vice president R&D for AMPAC fine chemicals.

Evans has 20 years of experience as an executive in the pharmaceutical space. He is the vice president Global Business Development and Portfolio with Pharmascience Inc. He has served in the senior roles at Johnson Matthew Teva USA, Qualitest Pharmaceuticals, Alita Pharmaceuticals and STADA.

Presently, Dr Wittmann serves as the chair of the Department of Marketing, Industrial Distribution, and Economics in the Collat School of Business at the University of Alabama at Birmingham. He has also served as chair of the Marketing and Merchandising Department at The University of Southern Mississippi. He has served as a marketing strategy consultant with a diverse group of companies.